Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the ...

City of Hope researchers have co-led the first study to demonstrate that characterizing genetic material near chromosomes ...

This seminar provides an overview of advances in the screening, diagnosis, and treatment of non-small-cell lung cancer and small ... nodes and occult distant metastases in patients who might otherwise ...

The Hsp27 protein can help cancer cells to protect themselves from cancer treatment. Hsp27 is only found in some types of lung cancer. The doctors in this trial think that by blocking Hsp27, or ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ('Kelun-Biotech', 6990.HK) today announced that results from its ...

What to know about new diagnostic tools, targeted medications, and other recent advances in the treatment of metastatic NSCLC ...

Thus, the treatment decision in p-N0 non-small-cell lung cancer (NSCLC ... we will further study the metastasis model of other distant metastases, such as liver metastasis and brain metastasis, and ...

Air pollution in India linked to rising lung cancer cases, emphasizing the urgent need for research and action.

Drugs that boost the body's immune system to fight disease are showing promise in treating a variety of cancers in earlier stages.

NEW YORK – Asandeutertinib, a derivative of AstraZeneca's Tagrisso (osimertinib), showed potential as a first-line treatment for patients with EGFR-mutated non-small cell lung cancer (NSCLC) with ...

a rare event for a fatal brain cancer with few treatment options, researchers reported on Sunday. The study, presented at the American Society of Clinical Oncology meeting in Chicago and published ...

CHICAGO – A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing brain cancer ... advanced disease spread and rapid ...